Signaling pathways
-
BA8883 RisvodetinibSummary: Risvodetinib (IkT-148009) is an orally active, selective, and brain-permeable inhibitor of. - BA8884 TunlametinibSummary: Tunlametinib is an anti-tumor compound.
-
BA8885 S49076Summary: S49076 is a novel and efficient inhibitor. - BA8886 BPI-9016MSummary: BPI-9016M is a potent, orally active, selective dual and tyrosine kinase inhibitor.
- BA8887 JNJ-38877618Summary: JNJ-38877618 is an effective.
- BA8888 SYN1143Summary: SYN1143 is a potent, selective and orally active dual inhibitor.
- BA8889 BAY-474Summary: BAY-474 is a tyrosine protein kinase inhibitor.
- BA8890 DalmelitinibSummary: Dalmelitinib is an orally active kinase-selective inhibitor that binds to the ATP-binding region of c-Met.
- BA8891 GemnelatinibSummary: Gemnelatinib is an inhibitor.
- BA8892 CanlitinibSummary: Canlitinib is a tyrosine kinase inhibitor.